eksentriline
Eksentriline is a medication used to treat attention deficit hyperactivity disorder (ADHD) in adults. It belongs to the class of stimulant medications, specifically a selective norepinephrine reuptake inhibitor (SNRI). The active ingredient in eksentriline is d-amphetamine, which is metabolized in the body to form the active form of the drug.
Eksentriline was approved by the U.S. Food and Drug Administration (FDA) in 2014 for the treatment of
Common side effects of eksentriline may include nausea, headache, and insomnia. Serious side effects are rare
Eksentriline is not approved for use in children or adolescents. The safety and efficacy of the medication